Streetbeat News

Products Services

GIB

CGI (NYSE:GIB) has been awarded a contract under the European Space Agency's 4S programme to lead the development of a cloud-based Universal Virtual Flight Data Recorder (UVFDR). The system will replicate the function of a traditional flight data recorder in a virtual environment, allowing immediate access to data in case of emergencies.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:08 am

IDXX

IDEXX Laboratories (NASDAQ:IDXX) has announced the launch of the first veterinary diagnostic test for detecting kidney injury in cats and dogs. The IDEXX Cystatin B Test will be included in renal health test panels and is expected to provide new clinical insights for an estimated two million patient visits annually.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:07 am

INVE

Identiv, Inc. (NASDAQ:INVE) has been granted FedRAMP Marketplace Authorization for its cloud-based Hirsch Velocity security management software, Velocity Vision video management system, and Hirsch Mx Controller products after a rigorous multi-year assessment process.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:06 am

ALDX

Aldeyra Therapeutics announced that its Phase 3 INVIGORATE-2 trial of Reproxalap ophthalmic solution for allergic conjunctivitis achieved statistical significance for the primary endpoint and all secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:06 am

DXC

NOK

Nokia partners with DXC Technology to launch DXC Signal Private LTE and 5G Solution, targeting market segments such as manufacturing, energy, healthcare, supply chain and logistics, transportation, and education.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:05 am

AVIR

Atea Pharmaceuticals has dosed the first patient in a Phase 2 study for the treatment of Hepatitis C with a combination of bemnifosbuvir and ruzasvir. The company focuses on the discovery and development of oral antiviral therapeutics for serious viral diseases.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:04 am

IOVA

Iovance Biotherapeutics announced the first patient has been randomized in the TILVANCE-301 Phase 3 trial, comparing lifileucel plus pembrolizumab versus pembrolizumab alone in frontline advanced melanoma treatment.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 11:04 am

XPEV

Chinese electric vehicle maker Xpeng has launched its assisted-driving technology in Beijing and three other cities, expanding its presence in the EV market.

Portfolio Pulse from Charles Gross

June 15, 2023 | 10:51 am

ESPR

Esperion Therapeutics (ESPR) is presenting today at 1:30 PM ET at the Endo 2023 conference.

Portfolio Pulse from Charles Gross

June 15, 2023 | 10:22 am

GGG

Graco introduces the Electric Variable Ratio Metering System (EVR), allowing manufacturers to change ratios while mixing, metering, and dispensing two-component (2K) material with the same equipment.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 10:17 am